GT Biopharma Inc. (GTBP)
Market Closed
26 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
5. 07
-0.39
-7.1429%
After Hours
$
+1.22 +24.0631% 6. 29
8.87M Market Cap
- P/E Ratio
- Div Yield
178,753 Volume
-10.8 Eps
$ 5.46
Previous Close 
Want to track GTBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
GT Biopharma Inc. (GTBP) Statistics
Valuation metrics
Market Cap 8.87M
Enterprise value 1.93M
Trailing P/E (ttm) -0.05
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 2.38
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.1
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 67.71K
Average volume (90 days) 60.2K
Price summary
52-Week low 4.91
52-Week high 28.75
Beta -
50-Day moving average 6.81
200-Day moving average 7.62
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -0.01
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 8 Sep 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -3.82%
Return on equity -4.43%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -14.22
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.19
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 2.61%
Book value per share (mrq) 2.3
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
